Equities

YungShin Global Holding Corp

3705:TAI

YungShin Global Holding Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)57.90
  • Today's Change-0.20 / -0.34%
  • Shares traded359.44k
  • 1 Year change+27.39%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TWDIncome statement in TWDView more

Year on year YungShin Global Holding Corp had little change in net income (from 839.04m to 827.30m) despite revenues that fell -3.88% from 7.31bn to 7.03bn.
Gross margin43.43%
Net profit margin14.40%
Operating margin16.02%
Return on assets9.03%
Return on equity13.88%
Return on investment12.89%
More ▼

Cash flow in TWDView more

In 2023, cash reserves at YungShin Global Holding Corp fell by 469.62m. However, the company earned 1.18bn from its operations for a Cash Flow Margin of 16.80%. In addition the company used 402.89m on investing activities and also paid 1.20bn in financing cash flows.
Cash flow per share5.29
Price/Cash flow per share10.97
Book value per share28.78
Tangible book value per share28.63
More ▼

Balance sheet in TWDView more

YungShin Global Holding Corp has a Debt to Total Capital ratio of 13.09%, a higher figure than the previous year's 3.51%.
Current ratio2.70
Quick ratio1.50
Total debt/total equity0.1855
Total debt/total capital0.1309
More ▼

Growth rates in TWD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -1.40%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)4.71%
Div growth rate (5 year)0.89%
Payout ratio (TTM)59.53%
EPS growth(5 years)3.34
EPS (TTM) vs
TTM 1 year ago
46.33
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.